f i n a l r e p o r t...3 2008). panax ginseng enhances the libido possibly through its effects on...
TRANSCRIPT
1
F I N A L R E P O R T
On the topic: “Evaluation of toxicity and hormone status of combination
of extracts from native medicinal plants in male inbred
mousses strain Balb/c”
Performers: 1. Assoc. Prof. Dr. Petia Genova-Kalou, PhD
Head-Leader of Laboratory of “Rickettsiae and tissue cultures”
Department of Virology, National Centre of Infectious and Parasitic Diseases
44A “Gen. Stoletov” Blvd., 1233 Sofia, Bulgaria
E-mail: [email protected]
Cell phone: 00359 889309967
2. Assist. Prof. Stefka Ivanova PhD
Department of Virology, National Centre of Infectious and Parasitic Diseases
44A “Gen. Stoletov” Blvd., 1233 Sofia, Bulgaria
3. Assoc. Prof. Andrey Tchorbanov PhD
Institute of Microbiology, Bulgarian Academy of Sciences
“Geogri Bontchev” Str., bl. 25, Sofia, Bulgaria
4. Adelina Pavlova – biologist
Department of Virology, National Centre of Infectious and Parasitic Diseases
44A “Gen. Stoletov” Blvd., 1233 Sofia, Bulgaria
5. Katia Georgieva-Dimitrova – lab technician
Department of Virology, National Centre of Infectious and Parasitic Diseases
44A “Gen. Stoletov” Blvd., 1233 Sofia, Bulgaria
Introduction
Sexual dysfunction includes erectile dysfunction or impotence, ejaculation
dysfunction, hypogonadism, etc. (Ho C. et al., 2011). It is a serious public health problem
among young as well as old men worldwide, with a prevalence of more than 20% (Laumann
E. et al., 2005). Current sexual dysfunction therapy lack satisfactory success due to adverse
effect, hence patients are seeking complementary and alternative medicine to treat sexual
dysfunction.
2
Ayurveda and other Indian literature mention the use of plants in various human
ailments. Researchers conducted in the last few decades on the plants mentioned in ancient
literature or used traditionally for sexual dysfunction. To achieve better sexual desire has led
to the development and use of different substances known as aphrodisiacs (Fugl-Meyer K. &
Fugl-Meyer A, 2000).
Nowadays, herbal medicines are widely used due to various reasons such as
appropriate and sustainable effectiveness, low side effects if used at appropriate doses, low
cost, easy access, etc. (Singh R. et al., 2013).
In our experiments we used four combinations of crude extracts from the following
medical plants: 1) Combination I - Epimedium grandiflorum (10% ikarine) (100 mg); Panax
ginseng extract from root (7 mg); L-arginine (250 mg); Zn (Zinc gluconate) (5 mg); Vitamin
C (32 mg); 2) Combination II – Pygeum africana (100 mg); Panax ginseng extract from root
(5 mg); L-arginine (250 mg); Zn (Zinc gluconate) (7 mg); Niacin (5 mg); Vitamin B6 (3 mg);
Vitamin B12 (10µg); Pantothenic acid (15 mg); 3) Combination III - Pygeum africana (100
mg); Epimedium grandiflorum (10% ikarine) (100 mg); Zn (Zinc gluconate) (7 mg); L-
arginine (180 mg); Vitamine B6 (3 mg); Vitamin B12 (10µg) and 4) Combination IV -
Tribulus terrestris (60% saponines) (320 mg); Niacin (5 mg); Pantothenic acid (20 mg);
Vitamin B6 (3 mg); Vitamin B12 (10µg); Zn (Zinc gluconate) (7 mg).
All of them are well-patronized medicinal herbs by Ayurvedic seers as well as by
modern herbalists. Throughout history, many different cultures have recognized the potential
use of listed above medicinal plants for prevention and treatment of various disorders. Many
indigenous plants have been claimed to have a sex-stimulating effect. These herbs were used
individually as a single therapeutic agent or as a prime or subordinate component with
combination of many vitamins. Some of them are:
• Tribulus terrestris (belonging to family Zygophyllaceae), known as Gokshur or
Gokharu, has been used for a long time for treatment of various kinds of diseases by anti-
inflammatory, anti-diabetic, hypolipidemic, cardiotonic, hepatoprotective, analgesic, anti-
spasmodic, anti-cancer, and anti-bacterial activities (Chhatre S. et al., 2014; Samani N. et al.,
2016). Tribulus terrestris has the potential to increase hormone levels of testosterone and
enhance premature ejaculation, stimulate androgen receptors in the brain, an action that can
help the body respond positively to circulating hormones (Ghosian Moghaddam M. et al.,
2013). It is proven, that Tribulus terrestris can raise serum testosterone levels by stimulating
androgen receptors in the brain, which causes the posterior pituitary gland to secrete
additional luteinizing hormone, thus stimulating the testes to secrete more testosterone
(Saudan C. et al., 2008).
• Panax ginseng is a perennial herb native to Korea and China and has been used as
an herbal remedy in eastern Asia for thousands of years. Modern therapeutic claims refer to
vitality, immune function, cancer, cardiovascular diseases, improvement of cognitive and
physical performance and sexual function. Root of the Korean ginseng has traditionally been
used to treat various diseases, particularly as an adaptogen since it is suggested to normalize
body functions and increase physical strength (Liu C. & Xiao P., 1992). It works as an
antioxidant by enhancing nitric oxide (NO) synthesis in the endothelium of corpora cavernosa
(CC); ginsenosides also cause transmural nerve stimulation-activated relaxation associated
with increased tissue cyclic guanosine monophosphate (Coon J. & Ernst E., 2002; Choi K,
3
2008). Panax ginseng enhances the libido possibly through its effects on the CNS and gonadal
tissues, as well as by increasing stamina during intercourse (Jia L. & Zhao Y., 2009).
• Epimedium grandiflorum (“horny goat weed”) have been utilized in Traditional
Chinese Medicine (TCM) for centuries to treat a variety of human illnesses. Recent
investigations into the properties of these plants have suggested that the most metabolically
active extract of Epimedium is icariin (ICA), a flavonol glycoside obtained from the aerial
part of the plant (Xin Z. et al, 2001). ICA has been demonstrated to enhance eNOS expression
and NO production in human endothelial cells as well as decrease caspase-3 expression and
cellular apoptosis in response to hydrogen peroxide (Wang Y. & Huang Z, 2005). It has
hondroprotective, anti-cancer, anti-viral activities, against cardiovascular diseases,
osteoporosis as well as play the role as aphrodisiac. Moreover, it can improve endocrine,
immune, and cognitive functions (Wu B. et al., 2012). In addition to an erectogenic role, it
has been suggested that ICA has testosterone-mimetic properties (Zhang Z. & Yang Q.,
2006). In addition, H. epimedii has been traditionally used in China to treat erectile
dysfunction (Low, W. & Tan, H, 2007).
• Pygeum africana (African cherry), which belongs to the plant family Rosaceae.
This evergreen miraculous plant is only found in sub-Saharan Africa and is highly sought
after owing to its unique anticancer phytochemicals (Ochwang'i, D. et al., 2014). The bark is
used in an attempt to treat fevers, malaria, wound dressing, arrow poison, stomach pain,
purgative, kidney disease, appetite stimulant, gonorrhoea, and insanity (Stewart K., 2003).
• L-arginine (or arginine) is a type of amino acid, and as we know, amino acids are
the “building blocks” of proteins. One of the biggest benefits of taking arginine is its ability to
improve blood flow and circulation. This has multiple benefits, including improving immune
function, fertility, detoxification and brain power. In the body, it is converted into nitric oxide,
which causes blood vessels to open wider. Another important aspect of L-arginine is that it
stimulates the production of certain hormones, especially beneficial growth hormones and
insulin that help usher glucose into cells to be used for growth and energy output (McConell
G., 2007).
• Vitamins (B6, B12, Niacin, Pantothenic acid). The cellular and tissue construction
of thyroid gland needs Vit. B complex. It energies increased hormone flow. B-complex
vitamin guard against impotence, premature ejaculation and premature menopause. Detoxifies
body and maintains healthy skin, tongue, nervous system. Have anti-depressant action
(Bijlwan A. & Kush L., 2013).
• Zinc is a naturally occurring mineral. It is important for growth and for the
development and health of body tissues. Zinc is necessary for the functioning of more than
300 different enzymes and plays a vital role in a large number of biological processes. Zinc is
a cofactor for the antioxidant enzyme superoxide dismutase (SOD) and is in a number of
enzymatic reactions involved in carbohydrate and protein metabolism. Zinc affects different
aspects of mammalian reproduction. Testicular disruption, impaired spermatogenesis and
subsequent poor semen parameters are found in males with zinc deficiency (Haffiez A. et al.,
1984). Zinc is necessary for the maturation of sperm and normal fetal development
(Dissanayake D., et al., 2009).
4
• Vitamin C is the most commonly used vitamin. It is a vitamin which takes part in
many biochemical processes in organisms. It is highly soluble in water and functions as an
effective reluctant. Vitamin C has been associated with fertility for many years and may have
evolutionary significance (Millar J., 1992). Vitamin C also contributes to the support of
spermatogenesis at least in part through its capacity to reduce α-tocopherol and maintain this
antioxidant in an active state (Davies M. et al., 1991). It may play a role in mediating
testosterone levels (Fernandes G. et al., 2011).
All experiments were performed on mice model Balb/c. The mice model is an
established model to study effects of agents on humans as they are easy and flexible to handle
and manipulate (Groothuis et al., 2007). Many authors have shown that similarities exist
between mouse and human reproductive organs and cycle thus, allowing careful extrapolation
of findings to human. The reproductive cycles of both mice and humans are under the control
of the endocrine system and are responsible for reproduction. Generally sexual behavior is
enhanced by elevated testosterone levels. Substances I, II, III and IV must induced changes in
neurotransmitter levels or their actions in the cells could also increase sexual behavior
(Yakubu M. et al., 2007).
Materials and methods
Medicinal plant extracts
For the purposes of the experiment were purchased crude medicinal plant extracts in
four combination: 1) Substance I – combination of Epimedium grandiflorum (10% ikarine)
(100 mg); Panax ginseng extract from root (7 mg); L-arginine (250 mg); Zn (Zinc gluconate)
(5 mg); Vitamin C (32 mg); 2) Substance II - combination of Pygeum africana (100 mg);
Panax ginseng extract from root (5 mg); L-arginine (250 mg); Zn (Zinc gluconate) (7 mg);
Niacin (5 mg); Vitamin B6 (3 mg); Vitamin B12 (10µg); Pantothenic acid (15 mg);
3) Substance III – combination of Pygeum africana (100 mg); Epimedium grandiflorum
(10% ikarine) (100 mg); Zn (Zinc gluconate) (7 mg); L-arginine (180 mg); Vitamine B6 (3
mg); Vitamin B12 (10µg) and 4) Substance IV – combination of Tribulus terrestris (60%
saponines) (320 mg); Niacin (5 mg); Pantothenic acid (20 mg); Vitamin B6 (3 mg); Vitamin
B12 (10µg); Zn (Zinc gluconate) (7 mg).
Mice
Male mice Balb/c (20–30 g) aged 8 – 12 months, with proved fertility were used in all
experiments. The animals were bought from a local Animal Center in Sofia (Bulgaria), and
kept in the Animal House of the Department of Virology, National Centre of Infectious and
Parasitic Diseases, Sofia (Bulgaria) for the duration of the experiments. The mice were
handled according to standard guidelines for the use and care of Laboratory experimental
animals as stated by the Ethical committee, National Centre of Infectious and Parasitic
Diseases, Sofia (Bulgaria) as well as the standard guidelines for use of laboratory animals
(National Institute of Health, Bethesda, MD: Public Health Service Policy on Humane Care
and Use of Laboratory animals, 2002) and acclimatized for one weeks before the experiment
proper. Twenty five mousse were housed in a polypropylene cages under controlled
5
environmental conditions of humidity and under 12h light and 12h dark conditions. The
temperature was maintained at 28 ± 1oC. They were fed with standard pellet feeds and water.
Mousses were divided in a five groups (one control and four treatment groups), containing
five animals in each group.
Group 1 - Male mouses Balb/c group – control
Group 2 – Male mouses Balb/c group – treated with Substance I
Group 3 - Male mouses Balb/c group – treated with Substance II
Group 4 - Male mouses Balb/c group – treated with Substance III
Group 5 - Male mouses Balb/c group – treated with Substance IV
Group 1 orally received distilled water (1 mL/kg) and served as the control. A single
oral dose of 400 mg/kg of the Substance I, II, III and IV were administered to Groups 2, 3, 4
and 5 respectively, by orally using intragastric tube. All the treatments were carried out for
7 days.
Evaluation of cytotoxicity of herbal combinations (Substances I, II, III and IV)
such as determined maximal non-toxic concentration (MNC) and cytotoxic
concentration 50% (CC50) in cell culture of murine origin
Cell viability was estimated by a modification of the MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide] assay (Mosmann T., 1983). The MTT reduction assay
was one of the most frequently used methods for measuring cell proliferation and
cytotoxicity. The intensity of colour (measured spectrophotometrically) of the MTT formazan
produced by living, metabolically active cells by measuring the activity of succinate
dehydrogenase, mostly located in mitochondria was proportional to the number of live cells
present. MTT was a yellow water-soluble tetrazolium dye that was reduced by live, but not
dead, cells to a purple formazan product that was insoluble in aqueous solutions.
In the experiments have been used one murine cell line: L929 (murine fibroblasts) from
European collection of cell cultures (ECACC). Cells were routinely maintained as adherent
cell cultures in DMEM (Dulbecco's Modified Eagle's medium, Sigma-Aldrich) medium and
containing 10% FBS (Fetal bovine serum, Gibco), 2mM L-glutamine (Sigma-Aldrich), 100
U/ml penicillin G sodium (Sigma-Aldrich), 100 µg/ml streptomycin sulphate (Sigma-Aldrich)
at 37oC, in a humidified air incubator containing 5% CO2. Cultivation of the cells was
continued with direct monitoring every two or three days using a phase contrast microscope.
The cells are harvested in 1x trypsin/EDTA solution (Sigma-Aldrich). Cells were passages 1:3
– 1:5 at a density around 5 – 6 x 104 cells/ml, while the passage was resuspended repeatedly.
Cell line was plated at an appropriate density (4,5 x 104 cells/well for L929) in 96-well plates
(Costar Corning) for 24 h. When the adherent cells were stuck to the plastic, the supernatant
was decanted and adding 50 µl of previous prepared dilutions of tested herbal combinations.
The well was completed with culture medium (150 µl) to a final volume of 200 μl. For 48 h
days the plate was incubated at 37oC and 5% content of CO2. Cells grown in medium without
compounds served as a control (negative control). After 48 h incubation, the medium was
replaced with MTT (Sigma-Aldrich) and dissolved at a final concentration of 5 mg/ml in
6
serum-free medium, for further 3 h incubation. Then, the MTT-formazan product was
solubilised in ethanol : DMSO (1 : 1), and the optical density was measured at a test wave
length of 540 nm in microplate reader (Bio-Tek Instruments) using wells without sample
containing cells as blanks. Each experiment was in triplicate. Cell viability was reported as
the % of viable cells in the wells treated with different concentrations of the tested compound
compared to the control untreated cells. MNC and CC50 were calculated from the constructed
“dose – cellular survival” curve.
Cytotoxic concentrations 50% (CC50) were defined as the concentrations of
the tested herbal combination at which 50% of the cells die as a result of toxicity of the
herbals.
Maximal non-toxic concentrations (MNC) were defined as the highest
concentrations of the tested herbal combination which do not cause injury or death of the
treated cells.
Acute toxicity study
To determine general short term toxicity, the animals were divided into 5 groups, each
containing 5 mice. Group I animals served as control and received distilled water in an
identical manner. The groups II, III, IV and V were given Substances I, II, III and IV (at the
respective doses - 100 mg/kg p.o., 200 mg/kg p.o. and 400 mg/kg p.o.). The animals were
observed continuously for 1 hr for any gross behavioural changes or death, if any, and
intermittently for the next 6 h and then again at 24 h after substance administrations. The
behavioural parameters like convulsions, hyper activity, sedation, grooming, loss of righting
reflex and increased respiration were observed.
Mounting behavior test
Mount is operationally defined as the male assuming the copulatory position but
failing to achieve intromission. Intromission was defined as the male’s penis entering the
vagina in association with thrusting behavior To quantify mounting behavior, non-estrous
female mice were paired with males treated with single dose of the drugs (400 mg/kg; p.o.).
Animals were observed for 3 h and their behaviors were scored as described (Lawler L.,
1984).
Males were placed individually in a glass cage. After 15 min of acclimatization, a non-
estrous female was introduced into the arena. The number of mounts was recorded during a
15 min observation period at the start of 1 h. The number of mounts was recorded by two
observers, who were uninformed about the drug treatment, during a 15 min observation period
at the start of each hour. All the experiments were performed between 09.00 to 12.00 h a.m. at
room temperature 26 – 27°C.
Hormone assay
On the 3th and 7th days of the experiments, from animals were collected blood samples
by cardiac puncture under anesthesia and isolated sera were analyzed for sexual hormone
secreted (testosterone (T)) and luteinizing hormone (LH). LH and T concentrations were
7
determined in duplicate using LH ELISA (IBL, Hamburg, Germany) and a Testosterone
Enzyme Immunoassay kit (Assay Designs, Ann Arbor, MI, USA), respectively, according to
the manufacturer's instructions. The detection limit for LH assay was 0,3 ng/mL. The
detection limit for the T assay was 10,0 pg/mL; cross-reactivity with corticosteroid and other
androgens was minimal (< 1%).
Histopathology and morphology examination
Small pieces of testis and epididymis were fixed in 10% buffered formalin and
processed for embedding in paraffin. Sections of 6 μm thicknesses were cut with a rotary
microtome (LEICA RM2235; Leica Biosystems Inc., Buffalo Grove, IL) and stained with
hematoxylin and eosin (HE) for morphology assessment. Histological sections were examined
using the light microscope (×100).
Statistical analysis
Mean±SD of the sex hormones, body and ovary weights were taken for analysis. The
data was tested for homogeneity of variance and significantly different results were
established by one-way ANOVA using the SPSS software application (version 16). Pair-wise
comparisons were made using the post hoc test. The accepted level of significance was set at
p<0.05.
Results
Evaluation of cytotoxicity of herbal combinations (Substance I and Substance II) such
as determined maximal non-toxic concentration (MNC) and cytotoxic concentration 50%
(CC50) in cell culture of murine origin
Evaluation of cytotoxicity was an important part of the assessment of potential
compounds since the beneficial drugs should be selective for drugs processes with little or no
effects on the metabolisms of normal cells. Both MNC and CC50 values were evaluated
simultaneously by morphological and by cell survival criteria. We used MTT-test,
determining the living and early apoptotic cells (Mosmann T., 1983). When microscopic
observation of the morphology of the monolayers were carried out at 48 h after the treatment
with tested herbal combination in different concentration range a typical cytopathology
characterizing the toxic effect was not registered in tested murine cell line L929.
Dynamics of survival of murine cells treated with Substances I, II, III and IV at 48 h were
presented in Figure 1.
The data presented here showed that the tested herbal combinations (Substances I, II,
III and IV) exhibit low cytotoxicity against murine cell line L929. The most cytotoxic is
Substance I if compared with other substances. These results were dose-dependent. In all
tested substances can not be determined cytotoxic concentration, which reduce cell viability
by 50%(CC50).
8
In vitro cytotoxicity data (MNC, mg/ml) for the tested herbal combinations (Substance
I, II, III and IV) were summarized in Table 1.
Table 1. Cytotoxic effect (MNC, mg/ml) of Substance I, II, III and IV on murine cell line
L929 at 48h
Substances MNC, mg/ml
I 0,0001
II 0,001
III 0,005
IV 0,001
Evaluation of acute toxicity study
The Substance I, II, III and IV administered orally in doses 400 mg/kg body weight
did not produce any evident sign of toxicity and any mortality in male mousses Balb/c when
observed up to 14 days after administration.
9
Effect of the Substances I, II, III and IV on mounting behavior of male mousses Balb/c
The effect of repeated oral administration (daily for 5 days) with single dose (400
mg/kg; p.o.) of the Substances I, II, III and IV is given in Table 2. All of the treated males
Balb/c mousses displayed excessive mounting behavior as compared to the control. The
number of mounts displayed by the Substances III and IV-treated male animals was more than
three times the values for the untreated controls during the observation period. However, the
Substances I and II-treated mice showed only marginal activity compared to Substances III
and IV-treated ones.
Table 2. Effect of a single dose (400 mg/kg; p.o.) of Substances I, II, III and IV of
mounting behavior of male mousses Balb/c
Group Number of mounts/15 min
1 h 2 h 3 h
Control 2,0 ± 0,9 1,0 ± 0,4 0,5 ± 0,2
Treated with
Substance I 2,5 ± 1,1 1,0 ± 0,4 0 ± 0,3
Treated with
Substance II 3,0 ± 0,9 1,0 ± 0,3 0,8 ± 0,3
Treated with
Substance III 12,0 ± 3,1 5,0 ± 2,4 3,0 ± 0,9
Treated with
Substance IV 11,0 ± 2,5 4,0 ± 1,2 1,0 ± 0,3
Luteinizing hormone (LH) and Testosterone (T) analysis
In the present study, we focused on the influence of botanical substances in relation to
testosterone (T) and luteinizing hormone (LH) concentrations.
Testosterone (T) is a naturally occurring steroid hormone from the androgen group, is
naturally produced in the body and is secreted primarily from the Leydig cells of the testes in
men (> 95%) and to a lesser extent in the theca cells of the ovaries in women, the zona
reticularis of the adrenal cortex, and the skin (Brooks R., 1975; Mooradian A. et al., 1987). It
is the main sex hormone and plays an important role in the development of the male
reproductive system and promotion of secondary sex characteristics such as muscle growth
and strength, bone mass, and growth of body hair (Mooradian A. et al., 1987). Levels of T are
typically more than five times higher in adult male than female (Laughlin G. et al., 2008).
Luteinizing hormone (LH) is produce by the pituitary in a pulsatile fashion, inducing
ovulation and maintenance of the corpus luteum in females. In adult males, LH regulates
spermatogenesis acting on Leydig cells located in the testes, by controlling T production
(Huhtaniemi I., 2015; Saez J., 1994). LH acts upon the Leydig cells of the testis and is
regulated by gonadotropin-releasing hormone (GnRH) (Nomura K. et al., 1989).The Leydig
cells produce testosterone (T) under the control of LH, which regulates the expression of the
enzyme 17β-hydroxysteroid dehydrogenase that is used to convert androstenedione, the
10
hormone produced by the testes, to testosterone, an androgen that exerts both endocrine
activity and intratesticular activity on spermatogenesis (Glage S. et al., 2013).
The effect of repeated oral administration with single dose (400 mg/kg; p.o.) of the
Substances I, II, III and IV is given in Table 3. The tested Substances I, II, III and IV acutely
administered at 400 mg/kg to male mosses significantly increased LH and T serum levels in
comparison with non-treated control group.
Table 3. The effect of a single dose (400 mg/kg; p.o.) of Substances I, II, III and IV on
T and LH level in control and treated groups
Groups T level (ng/ml) LH level (mIU/ml)
Control 0,270 ± 0,12 0,0125 ± 0,017
Treated with
Substance I 0,710 ± 0,20 0,079 ± 0,025
Treated with
Substance II 1,05 ± 0,41 0,125 ± 0,058
Treated with
Substance III 4,43 ± 1,04 0,207 ± 0,098
Treated with
Substance IV 6,49 ± 1,56 0,273 ± 0,066
Male mouses Balb/c treated with dose of 400mg/kg body weight with Substances III
and IV have a significant increase (up to 24 times) in level of serum T when compared to the
data of control group and treated mouses with Substances I and II. An increase in testosterone
level in male mouses Balb/c treated with Substances III and IV compared with the control
group has been associated with increase of sexual desire, penile tumescence, and rigidity. The
dose of 400mg/kg of Substances III and IV (up to 22 times) caused a significant increase in
LH (p < 0,01) as compared to control group and treated animals with Substances I and II.
Histological examination of testis of mouses Balb/c treated with Substances I, II, III
and IV in comparison with non-treated control group
In Figure 2 the testis of Substance-treated animals is compared with the testis of an
untreated male mousses Βalb/c. All stages of spermatogenesis were clearly: primary
spermatocytes, secondary spermatocytes, spermatogonia, spermatid and spermatozoa,
basement membrane and leydig`s cells (Figure 2A). No significant changes compared with
the control group could be found in testes morphology of treated with Substance II male
animals (Figure 2B).
The proliferation and increase of leygid’s cells was more pronounced in Substance III
treated mousses as compared to the control group (Figure 2C). The animal treated with
Substance IV showed higher number of spermatozoa in seminiferous tubules as compared to
C. articulata and both control treated groups, which further confirmed the increased
spermatogenesis, which is highly elaborated by an increase in spermatogenic elements as
described Figure 2D.
11
Figure 2 Histopathological examination of spermatogenesis in treated with Substances
II, III and IV male mice Balb/c and control group. Shown here are cross-sections
though the testes of male Balb/c mice
.
This study demonstrated the androgenic effects of the both combination Substance III
and Substance IV i.e. increased mounting, intromission, testes weight, spermatogenesis and
Leydig cell proliferation. These effects are explained by the increase in serum testosterone
and LH levels.
A. The light microscopic photograph of mouse
testis in control group staining with
(H & E 40×)
C. The light microscopic photograph of mouse
testis in group treated with Substance III
staining with (H & E)
D. The light microscopic photograph of mouse
testis in group treated with Substance IV
staining with (H & E)
B. The light microscopic photograph of mouse
testis in group treated with Substance II staining
with (H & E)
12
References
1. Ho C., Singam P., Hong G., Zainuddin Z. Male sexual dysfunction in Asia. Asian J
Androl. 2011, 13:537–42.
2. Laumann E., Nicolosi A., Glasser D. Sexual problems among women and men aged
40-80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and
Behaviors. Int J Impot Res, 2005, 17, 39–57.
3. Fugl-Meyer K., Fugl-Meyer A. Impact of erectile dysfunction on quality of life
patient and partner perspectives. Int J Impot Res., 2000, 12, 144–6.
4. Singh R., Ali A., Gupta G., Semval A., Jeyabalan G. Some medicinal plants with
aphrodisiac potential: A current status. J Acute Dis., 2013, 2(3): 179 – 188.
5. Chahatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological
overview of Tribulus terrestris. Pharmacogn. Rev., 8(15), 2014, 45 – 51.
6. Sammani N, Jokar A, Soveid M, Heydari M, Mosavat SH. Efficacy of Tribulus
Terrestris Extract on the Serum Glucose and Lipids of Women with Diabetes Mellitus. Iran J
Med Sci, 2016, 41(Suppl. 3): S5.
7. Ghosian Moghaddam, M., Khalili, M., Maleki, M., & Ahmad Abadi, M. The
Effect of Oral Feeding of Tribulus terrestris L. on Sex Hormone and Gonadotropin Levels in
Addicted Male Rats. Int. J. Fertil. Steril., 2013, 7(1): 57-62.
8. Saudan C., Baume N., Emery C., Strahm E., Saugy M. Short term impact of
Tribulus terrestris intake on doping control analysis of endogenous steroids. Forensic Sci Int,
2008, 178: e7-10.
9. Liu C., Xiao P. Recent advances on ginseng research in China. J
Ethnopharmacol,1992, 36: 27-38.
10. Coon J., Ernst E. Panax ginseng: a systematic review of adverse effects and drug
interactions. Drug Saf., 2002, 25(5): 323 – 44.
11. Choi K. Botanical characteristics, pharmacological effects and medicinal
components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin., 2008, 29: 1109–18.
12. Jia L, Zhao Y. Current evaluation of the millennium phytomedicine--ginseng (I):
etymology, pharmacognosy, phytochemistry, market and regulations. Curr Med Chem, 2009,
16: 2475-2484.
13. Xin Z., Kim E., Tian Z., Ling G., Guo Y. Icariin on relaxation effect of corpus
cavernosum smooth muscle. Chin Sci Bull., 2001, 46: 1186–90.
14. Wang Y. & Huang Z. Protective effects of icariin on human umbilical vein
endothelial cell injury induced by H2O2 in vitro. Pharmacol Res., 2005, 52: 174–82.
15. Zhang Z. & Yang Q. The testosterone mimetic properties of icariin. Asian J
Androl, 2006, 8: 601–5.
16. Kang, H., Choi, Y., Kwon, H., Lee, S., Kim, D., Sung, C., Park, Y., Dong, M.
Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major
components: In vitro and in vivo studies. Food Chem. Toxicol., 2012, 50, 2751–2759.
17. Wu, B., Chen, Y., Huang, J., Ning, Y., Bian, Q., Shan, Y., Cai, W., Zhang, X.,
Shen, Z. Icariin improves cognitive deficits and activates quiescent neural stem cells in aging
rats. J. Ethnopharmacol. 2012, 142, 746–753.
13
18. Low, W., Tan, H. Asian traditional medicine for erectile dysfunction. J. Men’s
Health Gender, 2007, 4, 245–250.
19. D. Ochwang'i, C. Kimwele, J. Oduma, P. Gathumbi, J. Mbaria, and S. Kiama,
Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya,
Journal of Ethnopharmacology, 2014, 151(3): 1040–1055.
20. Stewart, K. The African cherry (Prunus africana): can lessons be learned from an
over-exploited medicinal tree? Journal of Ethnopharmacology. 2003, 89 (1): 3–13
21. McConell G. Effects of L-arginine supplementation on exercise metabolism. Curr
Opin Clin Nutr Metab Care, 2007, 10(1): 46 – 51.
22. Bijlwan A. & Kush L. The dietary aphrodisiacs. Inter J Innov Res, 2013, 10:76-89
23. Haffiez A., el-Kirdassy Z., Monsour M., Sharada H., el-Zayat E. Role of zinc in
regulating the testicular function. Fertil Steril., 1984, 42: 459–65.
24. Dissanayake D., Wijesinghe P., Ratnasooriya W., Wimalasena S. Effects of zinc
supplementation on sexual behavior of male rats. J Hum Reprod Sci., 2009, 2(2): 57–61.
25. Yakubu M., Akanji M., Oladiji A. Male sexaual dysfunction and methods used in
assessing medicinal plants with aphrodisiac potentials. PHCOG Rev., 2007, 1(1):49-52.
26. Millar J. Vitamin C--the primate fertility factor? Med Hypotheses, 1992, 38: 292-5
27. Davies M., Austin J., Partridge D. Vitamin C: its chemistry and biochemistry. J
Biol Chem, 1991, 3(1): 21 – 33.
28. Fernandes G., Fernandez C., Campos K., Damasceno D., Anselmo-Franci J., et al.
Vitamin C partially attenuates male reproductive deficits in hyperglycemic rats. Reprod Biol
Endocrinol, 2011, 9: 100
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival:
Application to proliferation and cytotoxicity assays. J Immunol Meth, 1983, 65, (1): 55 – 63.
30. Lawler L. Ethnobotany of the Orchidaceace. In: Orchid Biology: Review and
Perspectives-3. Edited by: Arditti J. 1984, Ithaca, Cornell University Press, 27-149.
31. Brooks R. Androgens. Clin Endocrinol Metab, 1975, 4: 503-520.
32. Mooradian A., Morley J., Korenman S. Biological actions of androgens. Endocr
Rev., 1987, 8: 1-28
33. Laughlin G., Barrett-Connor E., Bergstrom J. Low serum testosterone and
mortality in older men. J Clin Endocrinol Metab, 2008, 93: 68-75
34. Huhtaniemi I. A short evolutionary history of FSH-stimulated spermatogenesis.
Hormones (Athens), 2015, 14: 468–78.
35. Saez J. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev.,
1994, 15: 574–626
36. Nomura K., Puett DW., Puett D., Shizume K., Liddle G. Extragonadal effects of
luteinizing hormone in mice. Acta Endocrinol (Copenhagen), 1989, 121(4): 587 – 94.
37. Glage S., Wittur I., Elfers C., Hedrich H., et al. Treatment of male mice with
gonadotropins to improve the fertilization rate and reproduction. Lab Animals, 2013, 47: 26-9.
8th August 2018 Performers:
14
1. Assoc. Prof. Dr. Petia Genova-Kalou, PhD
Head-Leader of Laboratory of
“Rickettsiae and cell cultures”
Department of Virology, National Centre of
Infectious and Parasitic Diseases, 44A “Gen.
Stoletov” Blvd., 1233 Sofia, Bulgaria
2. Assist. Prof. Stefka Ivanova PhD
Department of Virology,
National Centre of Infectious and Parasitic
Diseases, 44A “Gen. Stoletov” Blvd.,
1233 Sofia, Bulgaria
3. Assoc. Prof. Andrey Tchorbanov PhD
Institute of Microbiology,
Bulgarian Academy of Sciences,
“Geogri Bontchev” Str., bl. 25, Sofia,
Bulgaria